570 related articles for article (PubMed ID: 28283009)
21. Circumsporozoite protein as a potential target for antimalarials.
Fernández-Arias C; Mashoof S; Huang J; Tsuji M
Expert Rev Anti Infect Ther; 2015 Aug; 13(8):923-6. PubMed ID: 26081442
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
Zeeshan M; Alam MT; Vinayak S; Bora H; Tyagi RK; Alam MS; Choudhary V; Mittra P; Lumb V; Bharti PK; Udhayakumar V; Singh N; Jain V; Singh PP; Sharma YD
PLoS One; 2012; 7(8):e43430. PubMed ID: 22912873
[TBL] [Abstract][Full Text] [Related]
23. Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.
Clement F; Dewar V; Van Braeckel E; Desombere I; Dewerchin M; Swysen C; Demoitié MA; Jongert E; Cohen J; Leroux-Roels G; Cambron P
Malar J; 2012 Nov; 11():384. PubMed ID: 23173602
[TBL] [Abstract][Full Text] [Related]
24. Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains.
Herrera R; Anderson C; Kumar K; Molina-Cruz A; Nguyen V; Burkhardt M; Reiter K; Shimp R; Howard RF; Srinivasan P; Nold MJ; Ragheb D; Shi L; DeCotiis M; Aebig J; Lambert L; Rausch KM; Muratova O; Jin A; Reed SG; Sinnis P; Barillas-Mury C; Duffy PE; MacDonald NJ; Narum DL
Infect Immun; 2015 Oct; 83(10):3771-80. PubMed ID: 26169272
[TBL] [Abstract][Full Text] [Related]
25. Within-population genetic diversity of Plasmodium falciparum vaccine candidate antigens reveals geographic distance from a Central sub-Saharan African origin.
Tanabe K; Mita T; Palacpac NM; Arisue N; Tougan T; Kawai S; Jombart T; Kobayashi F; Horii T
Vaccine; 2013 Feb; 31(9):1334-9. PubMed ID: 23295064
[TBL] [Abstract][Full Text] [Related]
26. A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
Radin K; Clement F; Jongert E; Sterckx YG; Ockenhouse C; Regules J; Lemiale F; Leroux-Roels G
Malar J; 2016 Nov; 15(1):543. PubMed ID: 27825382
[TBL] [Abstract][Full Text] [Related]
27. Force Spectroscopy of the
Patra AP; Sharma S; Ainavarapu SR
J Biol Chem; 2017 Feb; 292(6):2110-2119. PubMed ID: 28031457
[TBL] [Abstract][Full Text] [Related]
28. Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP).
Sedegah M; Kim Y; Ganeshan H; Huang J; Belmonte M; Abot E; Banania JG; Farooq F; McGrath S; Peters B; Sette A; Soisson L; Diggs C; Doolan DL; Tamminga C; Villasante E; Hollingdale MR; Richie TL
Malar J; 2013 Jun; 12():185. PubMed ID: 23738590
[TBL] [Abstract][Full Text] [Related]
29. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.
Agrawal A; Bisharyan Y; Papoyan A; Bednenko J; Cardarelli J; Yao M; Clark T; Berkmen M; Ke N; Colussi P
Protein Expr Purif; 2019 Jan; 153():7-17. PubMed ID: 30081196
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
Wang LT; Pereira LS; Kiyuka PK; Schön A; Kisalu NK; Vistein R; Dillon M; Bonilla BG; Molina-Cruz A; Barillas-Mury C; Tan J; Idris AH; Francica JR; Seder RA
PLoS Pathog; 2021 Dec; 17(12):e1010133. PubMed ID: 34871332
[TBL] [Abstract][Full Text] [Related]
31. Optimization of a
Langowski MD; Khan FA; Bitzer AA; Genito CJ; Schrader AJ; Martin ML; Soto K; Zou X; Hadiwidjojo S; Beck Z; Matyas GR; Livingstone MC; Batchelor AH; Dutta S
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3114-3122. PubMed ID: 31988134
[No Abstract] [Full Text] [Related]
32. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific.
Alloueche A; Milligan P; Conway DJ; Pinder M; Bojang K; Doherty T; Tornieporth N; Cohen J; Greenwood BM
Am J Trop Med Hyg; 2003 Jan; 68(1):97-101. PubMed ID: 12556156
[TBL] [Abstract][Full Text] [Related]
33. Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization.
Wang L; Menting JG; Black CG; Stowers A; Kaslow DC; Hoffman SL; Coppel RL
Vaccine; 2000 Nov; 19(7-8):816-24. PubMed ID: 11115704
[TBL] [Abstract][Full Text] [Related]
34. Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
Chan JA; Wetzel D; Reiling L; Miura K; Drew DR; Gilson PR; Anderson DA; Richards JS; Long CA; Suckow M; Jenzelewski V; Tsuboi T; Boyle MJ; Piontek M; Beeson JG
PLoS One; 2019; 14(9):e0221733. PubMed ID: 31504038
[TBL] [Abstract][Full Text] [Related]
35. Rhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomes.
Phares TW; May AD; Genito CJ; Hoyt NA; Khan FA; Porter MD; DeBot M; Waters NC; Saudan P; Dutta S
Malar J; 2017 Mar; 16(1):115. PubMed ID: 28288639
[TBL] [Abstract][Full Text] [Related]
36. The
Singh SK; Plieskatt J; Chourasia BK; Singh V; Bolscher JM; Dechering KJ; Adu B; López-Méndez B; Kaviraj S; Locke E; King CR; Theisen M
J Biol Chem; 2020 Jan; 295(2):403-414. PubMed ID: 31792057
[TBL] [Abstract][Full Text] [Related]
37. A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1.
Caspers P; Etlinger H; Matile H; Pink JR; Stüber D; Takács B
Mol Biochem Parasitol; 1991 Aug; 47(2):143-50. PubMed ID: 1719416
[TBL] [Abstract][Full Text] [Related]
38. Restricted T-cell epitope diversity in the circumsporozoite protein from Plasmodium falciparum populations prevalent in Iran.
Zakeri S; Avazalipoor M; Mehrizi AA; Djadid ND; Snounou G
Am J Trop Med Hyg; 2007 Jun; 76(6):1046-51. PubMed ID: 17556609
[TBL] [Abstract][Full Text] [Related]
39. A chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein.
Kumar S; Zheng H; Sangweme DT; Mahajan B; Kozakai Y; Pham PT; Morin MJ; Locke E; Kumar N
J Immunol Methods; 2013 Apr; 390(1-2):99-105. PubMed ID: 23399449
[TBL] [Abstract][Full Text] [Related]
40. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
Birkett A; Lyons K; Schmidt A; Boyd D; Oliveira GA; Siddique A; Nussenzweig R; Calvo-Calle JM; Nardin E
Infect Immun; 2002 Dec; 70(12):6860-70. PubMed ID: 12438363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
